| Ytd | -54.53% | |
| 1y | -56.88% |
| Open | 1.74 | Prev Close | 1.77 | Low | 1.69 | High | 1.78 | Mkt Cap | 13.26M |
| Vol | 32.66K | Avg Vol | 115.82K | EPS | -4.91 | P/E | N/A | Forward P/E | -0.32 |
| Beta | N/A | Short Ratio | 0.71 | Inst. Own | 1.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 1.78 | 200-d Avg | 2.35 | 1yr Est | 70.00 |
SINTX Technologies (NASDAQ:SINT) held its second-quarter earnings conference call on Tuesday. Below
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab
Gainers Anbio Biotechnology (NASDAQ:NNNN) stock moved upwards by 16.9% to $6.49 during Friday's
Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales
Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and r
Sintx Technologies (NASDAQ: SINT - Get Free Report) and Avanos Medical (NYSE: AVNS - Get Free Report
Sintx Technologies (NASDAQ: SINT - Get Free Report) and Cooper Companies (NASDAQ: COO - Get Free Rep
Experts in implant retrieval, biomaterials and clinical practice examine the science, clinical exper
SALT LAKE CITY, Utah, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“S
SINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a company focused
SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SI
Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks Transcript
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.75) per share which missed the ana
SALT LAKE CITY, Utah, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SI
SALT LAKE CITY, Utah, July 28, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SI
SALT LAKE CITY, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SI
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advan
SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SI
Maxim Group analyst Anthony Vendetti reinstates SINTX Technologies (NASDAQ:SINT) with a Buy and a
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced bioma
SALT LAKE CITY, Utah, June 03, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SI
Shares of SINTX Technologies are trading lower Wednesday afternoon following the company's discl
https://www.sec.gov/ix?doc=/Archives/edgar/data/1269026/000149315226025377/form8-k.htm
HC Wainwright & Co. analyst Brandon Folkes reiterates SINTX Technologies (NASDAQ:SINT) with a
Salt Lake City, Utah--(Newsfile Corp. - May 17, 2026) - SINTX Technologies, Inc. (NASDAQ: SINT) ("SI
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(0.70) per share which missed the ana
Sintx Technologies (NASDAQ: SINT - Get Free Report) and Vasamed (OTCMKTS:VSMD - Get Free Report) are
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on SINTX Technologies (NASDAQ:S
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and l
Recent 2026 Milestones and Execution Progress::Completed first human implant of the SINAPTIC Foot &a
Clinical milestone, new President appointment, and platform expansion position SINTX for commercial
Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and a
Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advan
OPKO Health (NASDAQ: OPK - Get Free Report) and Sintx Technologies (NASDAQ: SINT - Get Free Report)
Appointment supports acceleration of revenue opportunities from SiNERGY ™ silicon nitride devices an
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and l
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceram
SINTX Technologies (NASDAQ:SINT) reported quarterly losses of $(1.19) per share which missed the ana
SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceram
SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceram
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies (NASDAQ:SINT) with a Buy and l